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KESAN SERAMIK KACA (GC) TERISI KOMPOSIT POLIMETIL 
METAKRILAT (PMMA) SIMEN TULANG 
ABSTRAK 
Dalam kajian ini, komposisi seramik kaca telah dihasilkan berdasarkan kepada sistem 
kaca Na2O-CaO-SiO2 dan ia telah digunakan sebagai pengisi di dalam komersil simen 
tulang PMMA (PALACOS LV®). Dalam penghasilan serbuk seramik kaca, pertamanya 
serbuk kaca yang terhasil di analisa menggunakan DSC/TGA dan XRF, kemudian ia 
dipadatkan dan dirawat haba pada suhu antara 850 hingga 1000 oC. Keputusan XRD 
bagi seramik kaca yang dirawat haba pada suhu 950 oC telah menunjukkan sifat kristal 
wollastonite (CaSiO3) dan sodium kalsium silikat (Na2Ca3Si6O16) yang tinggi. Ia juga 
menunjukkan kebioaktifan yang tinggi, yang mana ia menghasilkan lapisan apatit 
selepas direndam di dalam SBF selama 7 hari. Kemudian, seramik kaca yang dirawat 
haba pada suhu 950oC digunakan sebagai pengisi di dalam simen tulang PMMA dengan 
0, 4, 8, 12 dan 16 % berat pengisi dan keputusannya dibandingkan dengan komposit 
simen tulang terisi HA. Kesan pengisi terhadap sifat pengesetan, mekanikal dan terma 
telah dikaji. Didapati, suhu puncak dan masa doh simen tulang semasa pempolimeran 
menurun dengan meningkatnya peratus berat pengisi. Walaubagaimanapun, masa 
pengesetan tidak memberikan sebarang kesan dengan peningkatan peratus berat pengisi. 
Keputusan menunjukkan kekuatan lenturan dan keliatan patah menurun, manakala 
modulus lenturan meningkat dengan meningkatnya peratus berat pengisi. Selain itu, 
kestabilan terma, Tg dan modulus penyimpanan komposit simen meningkat dengan 
peningkatan bahan pengisi. Kajian morfologi ke atas bioaktiviti simen komposit 
menunjukkan pertumbuhan apatit di atas permukaan sampel GCBC4 dan GCBC8.  
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THE EFFECT OF GLASS-CERAMIC (GC) FILLED  
POLY(METHYL METHACRYLATE) BONE CEMENT COMPOSITES 
ABSTRACT 
In this study, a composition of glass-ceramic was fabricated based on the Na2O-CaO-
SiO2 glass system and was used as filler in commercial PMMA bone cement 
(PALACOS LV®). In producing the glass-ceramic powder, firstly the glass powders 
were analyzed using DSC/TGA and XRF, then it was compacted and heat treated at 
temperatures  between 850 to 1000oC. XRD result of glass-ceramic heat treated at 950oC 
shows high crystallization of wollastonite (CaSiO3) and sodium calcium silicate, 
(Na2Ca3Si6O16) in the glass composition. It also exhibits a high bioactivity which formed 
apatite after soaking in SBF for 7 days. Next, glass-ceramic heat treated at 950oC were 
used as a filler in the PMMA bone cement with filler loading of 0, 4, 8, 12, or 16 wt% 
and compared with HA composites. The effect of filler loadings on the setting, 
mechanical, and thermal properties were evaluated. It is found that the peak temperature 
and dough time during the polymerization of bone cement decreased with increasing 
filler loading. However, setting time did not show any significant trend. Result shows 
the flexural strength and fracture toughness decreased, and the flexural modulus 
increased as the filler loading increased. Besides, the thermal stability, Tg and storage 
modulus of cement composite increased with increasing filler loading. Morphological 
studies of the bioactivity of cement composite revealed the growth of apatite deposited 
on the GCBC4 and GCBC8 surface sample. 
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CHAPTER 1 
INTRODUCTION 
1.1 Background Study and Problem Statement 
  
Self-curing polymethylmethacrylate (PMMA) bone cements have been in the 
market for more than 50 years since their introduction by Sir John Charnley in 1958 
(Charnley, 1960).  It was first used in dental applications followed by the use in 
orthopaedic surgery for the fixation of total joint replacement such as for hip and knee 
prosthesis. In orthopaedics surgery, PMMA bone cement functions to transfer body 
weight and service loads from the prosthesis to the bone. PMMA bone cement has also 
been used to increase the load carrying capacity of the prosthesis-bone cement-bone 
system (Lewis, 1997; Kuehn et al., 2005a). Commercial bone cements are prepared by 
mixing powder and liquid components with proportion of powder to liquid (P/L) equal 
to 2. The powder component consists of PMMA or PMMA-based copolymers, and a 
polymerization initiator, usually benzoyl peroxide (BPO). The liquid component 
consists of methyl methacrylate (MMA) monomer, accelerator (usually N-N-dimethyl-
p-toluidine (DMPT)) and hydroquinone (HQ) as an inhibitor (Lewis, 1997; Hasenwinkel, 
2004; Kuehn et al., 2005a). In the operation theatre, the powder and liquid parts are 
mixed for 2-3 minutes until a dough mixture is obtained and then applied to the desired 
bone cavity. Due to a rapid polymerization reaction, bone cement hardens in the ensuing 
3-5 minutes (Serbetci et al., 2002). 
The main adverse effect of bone cement application is a strongly exothermic 
reaction at the bone and cement interface during the setting period. Maximum 
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temperatures in the range of 80 oC to 124 oC have been reported and these values could 
damage living tissue (Pascual et al., 1996). In addition, bone-PMMA bone cement 
interface is known as one of the weak-link zones in the prosthesis-bone cement-bone 
construct because it does not bind or adhere to bone and has poor mechanical properties. 
The lack of ability to bind to bone sometimes results in the widening of the intervening 
fibrous tissue layer between bone and PMMA cement, causing aseptic loosening of the 
cement (Shinzato et al., 2000; Kamimura et al., 2002). On the other hand, PMMA has 
been demonstrated to be biocompatible and easy to shape in vivo, allowing its use as a 
bone substitute in reconstructive surgery of the knee and in vertebroplasty. However, 
high shrinkage during curing, and the release of monomer to the surrounding tissue and 
again, the ability to bond directly to bone, pose several potential risks that lead to 
prosthesis loosening with time due to tissue necrosis, interfacial failure, and cement 
failure (Goto et al., 2005).  
Therefore, in an effort to improve their mechanical, thermal, handling and 
biocompatibility properties, investigations have been carried out on many different types 
of bone cements. Various approaches have been proposed and reported in the literature 
and one of them is bioactivation of PMMA bone cement by the incorporation of 
bioactive fillers in bone cement. The introduction of a bioactive phase in the PMMA 
matrix was suggested in order to enhance the quality of the bone-cement interface and to 
improve the setting and mechanical properties of the cement (Gilbert et al., 1995; Dalby 
et al., 2002). The in vivo studies of Kwon et al. (1997) found that there is new bone 
formation adjacent to the interface between the implant and surrounding bone as the 
amount of hydroxyapatite (HA) particles is increased. They also found that the 
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interfacial shear strength of the implanted specimens has a significant increase compared 
with the cement without HA.  
Goto et al. (2008)  reported that when using titania as filler in PMMA bone 
cement, lower peak temperature than for the unfilled cement were obtained. Besides HA 
and titania, Fujita et al. (1998) evaluated the bonding strength of the bioactive bone 
cements with higher percentage of apatite-wollastonite glass-ceramic powder. They 
found that bioactive bone cement had a higher bonding strength after surgery. The 
rationale for incorporating bioactive filler into PMMA cement had been also reported by 
Vallo (2000), and Dalby et al. (2002). From the literature, the cements showed good 
mechanical properties and excellent osteoconductivity by forming a biologically active 
bone-like apatite layer on their surfaces. However, trials using various fillers in bone 
cement produced unsatisfactory result due to deterioration of the mechanical properties 
after adding large weight percent (wt%) of the bioactive particles that caused difficulty 
in handling of the bone cement. The lack of bioactivity of the composite cement was 
also affected when the wt% of added bioactive particles is too small (Mousa et al., 2000).  
In this study, a glass-ceramic composition (55SiO2, 35CaO, 10Na2O and 3P2O5 
(wt%)) was developed and characterized. Trials to incorporate this glass-ceramic 
particle as filler into commercial PMMA bone cement (PALACOS® LV) that possesses 
favorable physical, mechanical, thermal and bioactivity properties was carried out. 
Different weight percent (wt%) of the fillers were used and as compared, incorporation 
of commercially HA filler into PMMA bone cement also being investigated in this study. 
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1.2  Objectives 
The objectives of project are listed as below: 
1)  To evaluate bioactivity of glass-ceramic filler in PMMA bone cement. 
2) To study the effect of the incorporation different weight percent of glass- 
 ceramic and HA fillers on the setting, mechanical, thermal and bioactivity 
 properties of PMMA bone cement composites. 
1.3  Outline of Thesis Structure 
Chapter 1:  
Introduction of PMMA bone cement and problem statement has been briefly explained 
in this chapter. The objectives of the study also have been stated.  
Chapter 2:   
This chapter reviews the literature on biomaterials and bioceramics field. In addition, 
literature on PMMA bone cement as polymer biomaterials and highlights on various 
studies and published works on incorporation of bioactive fillers into PMMA bone 
cement has been summarized in this chapter. 
Chapter 3:  
This chapter describes the detail of raw materials, chemicals and equipments that have 
been used to synthesize glass-ceramic and PMMA bone cement composites. 
Experimental and characterization methods have been explained in this chapter. 
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Chapter 4:  
Chapter 4 consists of results from the experiments and presented in charts, tables and 
micrographs. The results obtained from the experiments have been evaluated and 
discussed thoroughly. 
Chapter 5:  
Several conclusions of the present study are discussed in this chapter and a few 
suggestions and recommendations are proposed for future studies. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Biomaterials 
 
2.1.1 Introduction 
 
According to Black (1992) biomaterials can be defined as a material used in a 
medical device, intended to interact with biological systems. Over the years, various 
definitions of biomaterials have been proposed. For example, a biomaterial can be 
simply defined as a synthetic material used to replace part of a living system or to 
function in intimate contact with living tissue (Park & Bronzino, 2002). The other 
definition most commonly accepted is from the National Institutes of Health (NIH) 
which describes a biomaterial as: 
“any substance (other than a drug) or combination of substances, synthetic or 
natural in origin, which can be used for any period of time, as a whole or as part of a 
system which treats, augments, or replaces any tissues, organ, or functions of the body”  
(Williams, 1987). 
A material that can be used for medical application must possess a lot of specific 
characteristics, of which the first and foremost requirement is biocompatibility. 
Biocompatibility is the ability of a material to perform with an appropriate biological 
host response in a specific application (Williams, 1987). It means that, it should be non-
toxic and non-carcinogenic, cause little or no foreign-body reaction, and be chemically 
stable and corrosion resistant. The biomaterial also should possess adequate physical and 
mechanical properties to serve as augmentation or replacement of body tissues. For 
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practical use, a biomaterial should be able to formed or machined into different shapes, 
relatively cheap, and be readily available.  
Biomaterials have been widely used in application such as (Davis, 2003): 
(1) orthopaedics – total joint replacements (hip, knee), bone cements, bone void 
fillers, fracture fixation plates, and artificial tendons and ligaments; 
(2) cardiovascular applications - heart valves, pacemakers, artificial heart and 
ventricular assist device components, stents, and blood substitutes; 
(3) ophtalmics – contact lenses, corneal implants and artificial corneas, and 
intraocular lenses; 
(4) other applications- dental implants, cochlear implants, tissue screws and tacks, 
burn and wound dressings and artificial skin, tissue adhesives and scalants, drug-
delivery systems, and sutures. 
In general, biomaterials can be broadly categorized into the following categories: 
metals, ceramics, polymers, and composites. Table 2.1 illustrates some of the 
biomaterials types and their applications for these four groups of synthetic materials 
used for implantation.  
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Table 2.1: Classification of biomaterials types in medical devices and dental applications 
(Binyamin et al., 2006; Davis, 2003) 
 
 
Classification Biomaterial Examples of applications 
Metal 316L stainless steel Surgical instruments, orthopedic 
fixation devices, stents 
 Ti and Ti-containing alloys Fracture fixation, pacemaker 
encapsulation, joint replacement 
 Nickel-Titanium Alloy 
(Nitinol) 
Stents, orthondotic wires, bone plates 
 Platinum and platinum-
containing alloys 
Electrodes 
Polymer Polytetrafluoroethylene 
(Teflon, Gore-Tex) 
Vascular grafts, catheters, introduces 
 Poly(ethylene terephthalate)    
(polyester, Ethibond, 
Dacron) 
Vascular graft, drug delivery, non-
resorbable sutures 
 PMMA Bone cement, intraocular lenses, dental 
restorations 
 Polyurethane Cathethers, tubing, wound dressing, 
heart valves, artificial hearts 
 Silicone rubber 
(polydimethylsiloxane) 
 
Cathethers, feeding tubes, drainage 
tubes, introduces tips, flexible sheaths, 
gas exchange membranes 
 Polycarbonate Major component in renal dialysis 
cartridge, heart-lung machine,trocars, 
tubing interconnectors 
 Hydrogels (poly(ethylene 
oxide)), poly(ethylene 
glycol), poly(vinyl alcohol), 
etc.) 
Drug delivery, wound healing, 
hemostasis, adhesion prevention, 
contact lenses, extracellular matrices, 
reconstruction 
 Polyamides (nylon) Non-resorbable sutures 
 Polypropylene (i.e., prolene) Non-resorbable sutures, herni mesh 
Ceramic 
and glasses 
Alumina Joint replacement, dental implants, 
orthopaedic prostheses 
 Carbon Heart valves, biocompatible coatings, 
electrodes, dental implants 
 Hydroxyapatite Implant coatings, bone filler 
 Bioglass 
 
Metal prosthesis coating, dental 
composites, bone cement fillers 
 Porcelain Dental restorations 
Composites BIS-GMA-quartz/silica filler 
PMMA-glass filler 
Dental restorations 
Dental restorations (dental cements) 
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2.1.2 Classification of Biomaterials: Based on Types of Biomaterials 
2.1.2.1 Metallic Biomaterials 
Metals are inorganic materials that have unique atomic arrangements and 
bonding characteristics leading to enhanced mechanical, thermal and electrical 
properties. Their excellent electrical and thermal conductivity, fair biocompatibility and 
mechanical properties like high stiffness, high ductility and good wear resistance make 
them very ideal for a variety of medical applications especially for load bearing 
properties (Binyamin et al., 2006). One of the advantages of using metals as biomaterials 
is their availability and relative ease of processing from raw ore to finished products. 
Although they have excellent mechanical properties, metallic materials can have serious 
corrosion problems in an in vivo environment. The consequences of corrosion are the 
disintegration of the implant material per se, which result in releasing toxic metal ions to 
the body and also weakening the implants. Thus, corrosion resistance is a primary 
criterion in selecting metals for biomedical implants (Desai et al., 2008; Donglu, 2006). 
Metallic biomaterials have been used mainly for the fabrication of medical 
devices for the replacement of hard tissue such as total hip and knee prostheses and for 
fracture healing aids such as bone plates and screws, pins and spinal fixation devices. 
Besides orthopaedic, there are other markets for metallic implants and devices, including 
oral and maxillofacial surgery and dental implants (Niinomi, 2008). Some metals have 
also been used for repairing soft tissues as part of cardiovascular surgery as vascular 
stents, as pacemaker leads, and catheter guide wires. Besides that, surgical instruments, 
dental instruments, needles, staples, and implantable drug pump housings are also made 
from metallic materials (Davis, 2003).  
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Metallic biomaterials have the longest history among the various biomaterials. 
The main material groups that dominate biomedical metals are stainless steel, cobalt-
based alloy, titanium alloys, and shape memory alloys such as nickel-titanium alloy 
known as nitinol (Pelton et al., 2000; Niinomi, 2002; Bartel et al., 2006; Frosch & 
Sturmer, 2006). Generally, these materials are popular primarily because of their ability 
to bear significant loads, withstand fatigue loading, and undergo plastic deformation 
prior to failure. They also exhibit good biocompatibility, which does not cause serious 
toxic reactions in the human body.  
2.1.2.2 Polymer Biomaterials 
Polymers are the most widely used materials in biomedical applications. They 
have addressed neurological, cardiovascular, ophthalmic, and reconstructive pathologies 
with implantable devices designed to sustain or enhance human life. They have also 
been found useful in temporary therapies such as hemodialysis and coronary 
angioplasty. In addition, polymers are also used extensively in dentistry as composite 
(resin-ceramic), implants, dental cements, and denture bases and teeth (Davis, 2003). 
The advantage of using polymers as biomaterials, is their manufacturability. Polymers 
are easy to fabricate into various sizes and shapes (rod, film, fiber, sheet, etc) compared 
to metals and ceramics. They are also light in weight and have a wide range of 
mechanical properties for different applications.  The range of polymer biomaterials 
applications can be classed into types; synthetic and natural polymers (Donglu, 2006). 
Synthetic polymers are the majority of the polymer biomaterials that have been 
widely used in making various medical devices, such as disposable supplies, implants, 
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drug delivery systems and tissue engineering scaffolds. Synthetic polymers, then can be 
divided into two types: synthetic non-biodegradable polymers and synthetic 
biodegradable polymers. Although most synthetic non-biodegradable polymers were 
originally developed for non-biomedical uses, they are widely used as biomaterials 
mainly because of the necessary physical-mechanical properties they have. There are 
still no newly engineered biomaterials that can replace those non-degradable polymers. 
A good example is PMMA bone cement which has been used for fixation of artificial 
joint since 1943 and is still being widely used clinically nowadays (Kuehn, 2005). 
Example of others non-biodegradable polymers include polyvinyl chloride (PVC), 
polyethylene (PE), polypropylene (PP), polystyrene (PS), polycarbonate (PC), 
polyesters, polyamides (nylon), polyurethanes, and polysiloxanes (silicone) (Donglu, 
2006).  
Synthetic biodegradable polymers have attracted much attention in the last 
decade because they offer the advantage of being able to be eliminated from the body 
after fulfilling its intended use. Therefore, the second surgery can be avoided. This 
polymer is becoming more and more important in biomaterials and for the regeneration 
of tissues and organs. Example of this kind polymers include polyamino acid, poly 
(propylene fumarate) (PFF) and aliphatic polyester, such as poly (glycolic acid) (PGA), 
and poly (lactic acid) (PLA) (Donglu, 2006).  
Commonly encountered natural polymers are proteins, collagen, chitin and 
chitosan, hyaluronic acid, heparin and DNA. These materials are used as biomaterials 
largely because their structures are similar to the human tissue they intend to replace. 
These are important classes of biomaterials because of their biodegradation 
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characteristics and they are easily to find abundantly. However, the use of naturally 
occurring polymers often has some problem that provokes immune reaction of the host 
tissue. Therefore, many of them have to be chemically modified before being used as 
biomaterials. 
2.1.2.3 Ceramic Biomaterials 
Ceramics are non-metallic, refractory, polycrystalline compounds and usually 
inorganic material, which have some typical properties which are extremely hard, 
chemically stable, good wear resistance, and high durability that make them good 
materials as inert materials and useful for medical applications. But, ceramics are limited 
by their relative brittleness, high melting temperature and low electrical and thermal 
conductivity. Examples of ceramics include silicates, metallic oxides, carbides, sulfides, 
refractory hydrides, selenides and carbon structures such as diamond, graphite and 
pyrolized carbons. They are produced under a high temperature heat treatment process 
called firing. Ceramics used for the body are called bioceramics. Bioceramics used in 
fabricating implants typically can be classified as inert, bioactive and biodegradable or 
resorbable (Billotte, 2003; Binyamin et al., 2006; Navarro et al., 2008). The details of 
these bioceramics materials will be discussed in Section 2.2 
2.1.2.4 Composite Biomaterials 
 Composite materials are combinations of two or more distinct constituent 
materials or phases on a macroscopic scale and in which mechanical properties are 
significantly altered in comparison with the homogenous constituents (Lakes, 1993). 
Composite materials offer some advantages which include control over material bulk 
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properties and improvements in surface properties. The bulk properties of composite 
materials depend upon the volume fraction and the shape of the heterogenities. The 
principal inclusion shape categorized as the particle, fiber, and lamina. Particles and 
fiber reinforcements have been used to improve properties of biomaterials. For example, 
rubber used in catheters, where rubber gloves are usually reinforced with very fine 
particles of silica to make the rubber stronger and tougher. In dental composite 
materials, glasses or ceramic particles are blended in a polymeric organic resin matrix 
with interfacing silane coupling agents. Composite such as graphite fibers in epoxy resin 
can be as strong as steel when loaded in the fiber direction but much lighter. However, 
this material is compliant when loaded transversely to the fibers (Bhat, 2005). 
2.2 Bioceramics 
2.2.1 Introduction 
Park (2008) stated that bioceramics are ceramic materials that are used to make 
devices for the replacement, repair and reconstruction of diseased, damaged or “worn 
out” parts of living systems or to function in intimate contact with living tissues. In 
general, bioceramics show better biocompatibility with tissue response compared to 
polymer or metal biomaterials (Bilotte, 2003). Other than biocompatibility, ceramic 
materials have the following excellent properties: (a) non-toxic, (b) non-carcinogenic, 
(c) non-allergic, (d) non-imflammatory, and (e) biofunctional for its lifetime in the host. 
However, despite the excellent biocompatibility of bioceramics, the problems that occur 
in conventional ceramics also exist in bioceramics. The primary drawbacks of 
bioceramics are their brittleness, low strength, and inferior workability. Consequently, 
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bioceramics are very sensitive to notches or microcracks because they do not deform 
plastically (Bilotte, 2003). 
2.2.2 Classification of Bioceramics 
In general, bioceramics can be classified into three types based on their tissue 
response in the body. These are bioinert, bioactive, and bioresorbable (Thamaraiselvi & 
Rajeswari, 2004). The implant – tissue response are listed in Table 2.2. 
Table 2.2: Consequences of implant-tissue interactions (Hench & Wilson, 1993) 
 
 
Implant-tissue 
Reaction 
Consequence Example 
Bioinert Tissue forms a non-adherent 
fibrous capsule around the implant 
Alumina, Zirconia and Carbon 
Bioactive Tissue forms an interfacial bond 
with the implant 
Hydroxyapatite (HA),  
Bioactive glass 
Bioactive glass-ceramics 
Bioresorbable Tissue replace implant β-tricalcium phosphate (β-TCP), 
carbonated hydroxyapatite, 
calcium carbonate 
2.2.2.1 Bioinert Ceramics 
Bioinert ceramics are biocompatible materials that maintain their mechanical and 
physical properties after implantation. This bioinert material undergoes little or no 
chemical reactivity, even after long term of exposure to the physiological condition and 
therefore, shows minimal interfacial bonds with the living tissues (Bhat, 2005). 
Examples of this type of materials include alumina (Al2O3), zirconia (ZrO2), pyrolitic 
carbon, and silicon nitrides. Bioinert ceramics are very popular in orthopaedics and 
commonly used for structural support applications. They are also known to have 
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excellent wear properties and are therefore useful for gliding functions (Binyamin et al., 
2006; Li & Hastings, 1998). 
2.2.2.2 Bioresorbable Ceramics 
Bioresorbable ceramics refer to materials that, upon placement within the human 
body, would start to dissolve and slowly be replaced by advancing tissues. In other 
words, resorbable implants are designed to degrade gradually with time and be replaced 
with natural tissues (Bilotte, 2003). It leads to tissue regeneration instead of replacement. 
The rate of degradation varies from one material to another. The advantage of this type 
of implant is that it will be replaced by normal functional bone, thus eliminating any 
long term biocompatibility problems. However, during the remodeling process, the load 
bearing capacity of the implant could possibly be weakened and resulted in mechanical 
failure. Therefore, the resorption rates of the material should be matched with the repair 
rates of body tissues (Hench & Wilson, 1993). 
2.2.2.3 Bioactive Ceramics 
Hench and Anderson (1993) define bioactive materials as a material that elicits a 
specific biological response at the interface of the material which results in the formation 
of a bond between the tissues and the material. When a bioactive material is implanted 
into the human body, it will interact to some extent with the surrounding bone or other 
tissue. An ion-exchange reaction between the bioactive implant and surrounding body 
fluids results in the formation of a bone-like apatite layer on the implant that is 
chemically and crystallographically equivalent to the mineral phase in the bone, which 
promotes the bonding between the natural tissues and the material (Liu et al., 2008). 
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Typical examples of conventional bioactive ceramics used in orthopaedic surgery are 
synthetic HA, Bioglass®, Ceravital®, and A-W Glass-ceramic (Hench, 1998; Ratner et 
al., 2007).  
The ability for the formation of this apatite layer on the implanted substrate in 
the body environment is essential for the direct bonding to living bone. An estimate of 
the potential for apatite layer formation on a ceramic material is carried out by in vitro 
testing. Kokubo and his colleagues developed a simulated body fluid (SBF) similar with 
regard to inorganic ions to the human body plasma (Kokubo et al., 1990; Kokubo & 
Takadama, 2006). Materials that form apatite in SBF are expected to form apatite in the 
body and bond to living bone; therefore, SBF has been widely used to estimate the in 
vivo bone bioactivity of various types of bioactive materials (Kamitakahara et al., 2009). 
2.2.3 Applications of Bioceramics 
Bioceramics are produced in a variety of forms and phases, and serve many 
different functions in the repair of the human body, which are summarized in Table 2.2. 
Most applications of bioceramics relate to the repair of the skeletal system, composed of 
bones, joints, and teeth, and to augment both hard and soft tissues. These repairs become 
necessary when the existing part becomes diseased, damaged, or just simply worn out. 
There are many other applications of bioceramics including pyrolotic carbon coatings 
for heart valves and special radioactive glass formulations for the treatment of certain 
tumors (Carter & Norton, 2008). In other situations, bioceramics are used as reinforcing 
components in a composite, combining the characteristics of both components into a 
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new material with enhanced mechanical and biochemical properties. Figure 2.3 shows a 
number of clinical uses of bioceramics (Hench & Wilson, 1993; Ishikawa et al., 2003). 
Ceramics are also widely used in denstistry as restorative materials, gold 
porcelain crowns, glass-filled ionomer cements, endodontic treatments, dentures, and so 
forth and the materials used in these applications are called dental ceramics. Ceramics 
and glasses have been used for a long time outside the body for a variety of applications 
in the health care industry. Eye glasses, diagnostic instruments, chemical ware, 
thermometers, tissue culture flasks, chromatography columns, lasers and fibre optics for 
endoscopy are commonplace products in the industry (Hench & Wilson, 1993). 
Table 2.3: Form, phase and function of bioceramics (Hench & Wilson, 1993) 
 
 
Form Phase Function 
Powder Polycrystalline 
Glass 
Space filling, therapeutic treatment, 
regeneration of tissues 
Coating Polycrystalline 
Glass 
Glass-ceramic 
Tissue bonding, thromboresistance, corrosion 
protection 
Bulk Single crystal 
Polycrystalline 
Glass 
Glass-ceramic 
Composite (multi-phase) 
Replacement and augmentation of tissue, 
replace functioning parts 
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 Figure 2.1: Clinical uses of bioceramics (Hench & Wilson, 1993) 
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2.3 Bioactive Glasses and Glass-ceramics 
2.3.1  Bioactive Glasses 
 The first and most thoroughly studied bioactive glass is known as Bioglass® 
455S (Hench, 1991). Bioglass® 45S5 is a multicomponent oxide glass where the main 
composition SiO2, Na2O, CaO and P2O5. The majority of bioactive glasses and glass-
ceramics are based on these four components and all current bioactive glasses are 
silicates. There are three key compositional features to these bioactive glasses that 
distinguished them from traditional soda-lime-silica glasses: a) less than 60 wt% SiO2, 
b) high Na2O and CaO contents, and c) high CaO/P2O5 ratio. These compositional 
features make their surface highly reactive when exposed to an aqueous medium such as 
the body fluids (Davis, 2003). The 45S5 composition and several typical bioactive 
glasses are given in Table 2.4. 
Table 2.4: Composition (wt%) and mechanical properties of bioactive glasses (Cao & 
Hench, 1996) 
 
 
Component 45S5 
Bioglass® 
45S5.4F 
Bioglass® 
45B15S 
Bioglass® 
52S4.6 
Bioglass® 
55S4.3 
Bioglass® 
SiO2 45 45 30 52 55 
P2O5 6 6 6 6 6 
CaO 24.5 14.7 24.5 21 19.5 
Na2O 24.5 24.5 24.5 21 19.5 
CaF2  9.8    
B2O3   15   
Structure Glass and  
Glass-
ceramic 
Glass Glass Glass Glass 
This work is studied by Hench and co-workers and summarized in the ternary 
SiO2-Na2O-CaO diagram as shown in Figure 2.2. It illustrates the compositional 
dependence of bone bonding and soft tissue bonding for the SiO2-Na2O-CaO glasses. 
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Composition in the middle of the diagram (region A) forms a bond with bone and is 
defined as bioactive bone bonding boundary. When the concentration of SiO2 in the 
glass network exceeds 55% the rates of reaction decrease, and bonding to bone is very 
slow. Silicate glasses within region B behave as almost bioinert materials and elicit 
formation of a fibrous capsule at the implant-tissue interface. Glasses within region C 
are resorbable and disappear within 10-30 days of implantation. Compound of glasses 
within region D are not technically interesting and therefore, have not been tested as 
implants (Cao & Hench, 1996). 
 
Figure 2.2: The SiO2-CaO-Na2O ternary phase diagram (Cao & Hench, 1996) 
The main advantage of the bioactive glasses is the rapid surface reaction that 
brings about fast connections for tissue bonding and their primary disadvantages are 
mechanical weakness and low fracture toughness due to an amorphous two-dimensional 
glass network. The bending-tensile strength of most composition of bioactive glass vary 
between 40-60MPa, which make them unsuitable for load-bearing applications and find 
use as coatings on metals, in low-loaded or compressively loaded devices, in the form of 
powders or as the bioactive phase in composites (Hench & Wilson, 1993). 
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Bioactive glasses may be produced in various forms depending on the repair 
function they will serve. One of the most successful uses of bioactive glass is as 
replacement for the ossicles (tiny bones) in the middle ear and to repair the bone that 
supports the eye. Cone-shaped plugs of bioactive glasses also have been used in oral 
surgery to fill the defect in the jaw created when a tooth is removed. In powder form, 
bioactive glasses are used in the treatment of periodontal disease and for the treatment of 
patients with paralysis of one of the vocal cords (Carter & Norton, 2007). 
2.3.2  Bioactive Glass-ceramics 
2.3.2.1 Glass-ceramic Processing 
James, (1995) defined that glass-ceramics are materials obtained by controlled 
crystallization of certain glasses. Bioactive glass-ceramics have been developed to 
improve the mechanical performance of bioactive materials, or to introduce other 
interesting properties such as the machinable glass-ceramic Bioverit®. The formation of 
glass-ceramics is influenced by two important factors which are nucleation and growth 
of small crystal (< 1µm in diameter) and uniform size distribution. It is estimated that 
about 1012 to 1015 nuclei per cubic centimeter are required to achieve such small crystals. 
In addition to the metallic agents already mentioned, Pt groups, TiO2, ZrO2 and P2O5 are 
widely used as nucleating agents. The nucleation of glass is carried out at temperatures 
much lower than the melting or glass transition temperature, at which the melt viscosity 
is in the range of 1011 to 1012 Poise for at least 1 to 2 h. To obtain a more 
microcrystalline phase, the glass is further heated to an appropriate temperature for 
maximum crystal growth. In this process, deformation of the products, phase 
transformation within the crystalline phases, or re-dissolution of some of the phases 
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should be avoided. The crystallization is usually more than 90% complete when grain 
sizes are 0.1 to 1 µm, which are much smaller than in conventional ceramics. Figure 2.3 
is a schematic representation of the temperature –time cycle for a glass-ceramic. 
   Melt & forming 
             Growth 
 Nucleation 
              Room temperature 
 
Temperature 
                                                          Time 
Figure 2.3: Temperature-time cycle for a glass-ceramic 
2.3.2.2 Properties of Glass-ceramics 
Glass-ceramics have several desirable properties compared with glasses and 
ceramics. The thermal coefficient of expansion is very low. Due to the controlled grain 
size and improved resistance to surface damage, glass-ceramics can have at least double 
the tensile strength (from 100 to 200 MPa). The resistance to scratching and abrasion of 
glass-ceramics is similar to that of sapphire. The modulus of elasticity is of the order of 
100 GPa, and the compressive strength is about five times the tensile strength, as given 
in Table 2.5.  
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Table 2.5: Mechanical properties of glass-ceramics (Park, 2008) 
 
Properties Bioglass® Ceravital® A-W  Glass-
ceramic® 
Young’s modulus (GPa) 
Tensile strength (MPa) 
Compressive strength (MPa) 
Bending strength (MPa) 
Hardness (Vickers) 
Fracture toughness (MPa.m1/2) 
35 
200 
42 
160-190 
458 
2.0 
100-159 
400 
500 
130 
294 
4.6 
118 
- 
1080 
215 
680 
3.34 
A negative characteristic of the glass-ceramic is its brittleness. In addition, 
limitations on the compositions used for producing a biocompatible glass-ceramics 
hinder the production of glass-ceramic which has substantially higher mechanical 
strength. Thus, glass-ceramics cannot be used for making major load-bearing implants 
such as joint implants. However, they can be used as fillers for bone cement, dental 
restorative composites, and coating material (Billotte, 2003). 
2.3.2.3 Commercial Bioactive Glass-ceramics 
Several kinds of glass-ceramics compositions are bioactive and their behaviour 
in the body is very similar to that of bioactive glass which has an ability to form a strong 
interfacial bond with hard and soft tissues. There are three examples of well-known 
bioactive glass-ceramics that have been developed for implantation:  machinable  glass-
ceramic (Bioverit® I), Ceravital® and A-W Glass-ceramic® (Carter & Norton, 2007). 
Table 2.6 shows compositions of some bioactive glass-ceramics.  
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Table 2.6: Compositions of some bioactive glass-ceramics (Cao & Hench, 1996; Park, 
2008) 
Type SiO2 CaO Na2O P2O5 MgO K2O 
A-W Glass-Ceramic® 34.2 44.9 - 16.3 4.6  
Ceravital®  40-50 30-35 5-10 10-15 2.5-5 0.5-3 
Bioverit® I 29.5-50 13-28 - 8-18 6-28 - 
All type of bioactive glass-ceramic composition in weight percent (wt%). In addition, 
Al2O3 (0-19.5), Na2O/K2O (5.5-9.5), F (2.5-7), Cl (0.01-0.6) and TiO2 (additions) are 
present in Bioverit® I. A-W Glass-ceramic® has CaF2 (0.5%). 
 
 
 A-W Glass-ceramic® is produced by crystallization of a glass of composition as 
can be seen in Table 2.6. The crystalline phases are oxyfluroapatite 
[Ca10(PO4)6(OH1F2)] and β-wollastonite (CaO-SiO2) and also content a residual glassy 
matrix.  A-W Glass-ceramic® has excellent mechanical properties and forms a bond with 
bone that has very high interfacial bond strength. This type of glass has been used 
successfully in hundreds of patients for replacing part of the pelvic bone and in vertebral 
surgery (Hench & Kokubo, 1998). Ceravital® has been successfully used clinically in 
middle ear surgery to replace damaged bone. In this application the mechanical 
properties of the material are sufficient to support the minimal applied loads. To control 
the dissolution rate, Al2O3, F, and Cl are added in Ceravital® glass-ceramic. Bioverit® I 
is a mica-apatite glass-ceramic and known as machinable bioactive glass-ceramic. The 
key to the development of Bioverit® I was to form a phase separated base glass 
consisting of three glassy phases and to control the nucleation and crystallization by heat 
treating the glass. 
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2.3.2.4 Mechanism of Bioactive Bonding 
Bonding of bone to bioactive glasses and glass-ceramics involves 11 reaction 
stages summarized in Figure 2.4. The first five reaction stages that occur on the surface 
of bioactive glass and glass-ceramic do not depend on the presence of tissues. They 
occur in distilled water, tris-buffer solutions or SBF, and have been well studied using 
Fourier transform infrared (FTIR) spectroscopy, Auger electron spectroscopy, and 
electron microprobe analysis. These reactions result in a hydroxycarbonate apatite 
(HCA) crystal layer forming on the implant surface. Stages 6-11 are necessary for the 
implant to bond to tissues. 
      Increasing Time 
11- Crystallization of matrix  
10-Cellular attachment 
9- Differentiation of stem cells 
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 8- Attachment of stem cells 
7- Action of macrophages Log t 
6- Adsorption of biologic moieties in HCA layer 
5- Nucleation and crystallization of hydroxyl carbonate 
apatite (HCA) 
4- Precipitation of amorphous calcium phosphate 
2, 3- Dissolution and repolymerization of surface silica 
1- Sodium hydrogen ion exchange 
0- Initial glass surface 
Figure 2.4: Sequence of interfacial reactions involved in forming a bond between bone 
and bioactive glasses (Cao & Hench, 1996) 
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